NCT02584257 - Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma | Biotech Hunter

Enrollment

217

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2016

Conditions

Mild Persistent Asthma

Interventions

OTHER

methacholine chloride

DRUG

placebo ProAir HFA

DRUG

ProAir HFA

DRUG

Lupin albuterol HFA MDI

DRUG

placebo Lupin albuterol HFA MDI

Trial Locations (17)

20814

Investigational Research Center Site #105, Bethesda

21236

Investigational Research Center Site #109, Baltimore

27607

Investigational Research Center Site #102, Raleigh

32308

Investigational Research Center Site #106, Tallahassee

45231

Investigational Research Center Site #111, Cincinnati

63141

Investigational Research Center Site #108, St Louis

68123

Investigational Research Center Site #115, Bellevue

74136

Investigational Research Center Site #118, Tulsa

90274

Investigational Research Center Site #113, Rolling Hills Estates

92123

Investigational Research Center Site #112, San Diego

92647

Investigational Research Center Site #110, Huntington Beach

92691

Investigational Research Center Site #114, Mission Viejo

95117

Investigational Research Center Site #116, San Jose

97202

Investigational Research Center Site #107, Portland

97504

Investigational Research Center Site #101, Medford

02747

Investigational Research Center Site #103, North Dartmouth

08558

Investigational Research Center Site #104, Skillman

All Listed Sponsors

lead

Lupin, Inc.

INDUSTRY